Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-22 18:18 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Belgium · Germany · Mexico · Romania · United States
Registry dates and results
Start: 2022-11-30. Completion: 2024-08-12 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Tirzepatide (drug) — also listed as: LY3298176
Dulaglutide (drug) — also listed as: LY2189265
Where the study takes place — 38 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
ALL Medical Research, LLC Cooper City, Florida, United States
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Metabolic Research Institute, Inc. West Palm Beach, Florida, United States Site recruitment: Not reported
NorthShore University Health System Skokie, Illinois, United States Site recruitment: Not reported
Iowa Diabetes and Endocrinology Research Center West Des Moines, Iowa, United States Site recruitment: Not reported
Clinvest Research LLC Springfield, Missouri, United States Site recruitment: Not reported
Alliance for Multispecialty Research, LLC Norman, Oklahoma, United States Site recruitment: Not reported
Juno Research Houston, Texas, United States Site recruitment: Not reported
Biopharma Informatic, LLC Houston, Texas, United States Site recruitment: Not reported
Juno Research Houston, Texas, United States Site recruitment: Not reported
Southern Endocrinology Associates Mesquite, Texas, United States Site recruitment: Not reported
North Hills Family Medicine/North Hills Medical Research North Richland Hills, Texas, United States Site recruitment: Not reported
Imelda General Hospital Bonheiden, Antwerpen, Belgium Site recruitment: Not reported
Antwerp University Hospital Edegem, Antwerpen, Belgium Site recruitment: Not reported
ZNA Jan Palfijn Merksem, Flanders, Belgium Site recruitment: Not reported
AZ Nikolaas Sint-Niklaas, Oost-Vlaanderen, Belgium Site recruitment: Not reported
UZ Leuven Leuven, Vlaams-Brabant, Belgium Site recruitment: Not reported
Az Damiaan vzw Ostend, West-Vlaanderen, Belgium Site recruitment: Not reported
InnoDiab Forschung Gmbh Essen, North Rhine-Westphalia, Germany Site recruitment: Not reported
Institut für Diabetesforschung GmbH Münster Münster, North Rhine-Westphalia, Germany Site recruitment: Not reported
Studienzentrum Dr. Tasso Bieler Riesa, Saxony, Germany Site recruitment: Not reported
RED-Institut GmbH Oldenburg in Holstein, Schleswig-Holstein, Germany Site recruitment: Not reported
Medizinisches Versorgungszentrum am Bahnhof Spandau Spandau, State of Berlin, Germany Site recruitment: Not reported
Diabeteszentrum Hamburg West Hamburg, Germany Site recruitment: Not reported
Diseno y Planeacion en Investigacion Medica Guadalajara, Jalisco, Mexico Site recruitment: Not reported
Unidad de Investigación Clínica y Atención Médica HEPA Guadalajara, Jalisco, Mexico Site recruitment: Not reported
Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares Mexico City, Mexico City, Mexico Site recruitment: Not reported
Instituto de Diabetes, Obesidad y Nutricion Cuernavaca, Morelos, Mexico Site recruitment: Not reported
Hospital Universitario "Dr. Jose Eleuterio Gonzalez" Monterrey, Nuevo León, Mexico Site recruitment: Not reported
Unidad biomedica avanzada monterrey Monterrey, Nuevo León, Mexico Site recruitment: Not reported
Hospital Universitario "Dr. Jose Eleuterio Gonzalez" Monterrey, Nuevo León, Mexico Site recruitment: Not reported
Centro de Estudios de Investigacion Metabolicos y Cardiovasculares Ciudad Madero, Tamaulipas, Mexico Site recruitment: Not reported
Investigacion En Salud Y Metabolismo Sc Chihuahua City, Mexico Site recruitment: Not reported
Diabdana Oradea, Bihor County, Romania Site recruitment: Not reported
Mariodiab Clinic Brasov, Brașov County, Romania Site recruitment: Not reported
Geea Medical Easy Diet Bucharest, Bucharest, Romania Site recruitment: Not reported
Gama Diamed Mangalia, Constanța County, Romania Site recruitment: Not reported
CMI DNBM Dr. Pop Lavinia Baia Mare, Maramureş, Romania Site recruitment: Not reported
Clinica Korall Satu Mare, Romania Site recruitment: Not reported
Start: 2024-02-06. Completion: 2025-04-09 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
HS-20094 (drug)
Dulaglutide (drug)
Palcebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Tianjin Medical University General Hospital (Zhu Xianyi Memorial Hospital) Tianjin, Tianjin Municipality, China Site recruitment: Not reported
Diabetes Mellitus, Type 2; Cardiovascular Diseases
Sponsor
Janssen Research & Development, LLC
Countries with listed sites
United States
Registry dates and results
Start: 2018-02-22. Completion: 2018-06-25 (may be estimated). No results posted in this registry response.
Products and interventions (9)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Canagliflozin (drug)
Empagliflozin (drug)
Dapagliflozin (drug)
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (drug)
Glucagon-like Peptide-1 (GLP-1) Agonist (drug)
Anti-hyperglycemic Agents (AHA) (drug)
Thiazolidinediones (TZD) (drug)
Sulfonylureas (SU) (drug)
Insulin (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Janssen Investigative Site Titusville, New Jersey, United States Site recruitment: Not reported
Start: 2023-01-10. Completion: 2024-10-12 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Ecnoglutide high dosage (drug) — also listed as: XW003
Ecnoglutide low dosage (drug) — also listed as: XW003
Dulaglutide (drug)
Metformin (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
ZHONGSHAN Hospital Shanghai, Shanghai Municipality, China Site recruitment: Not reported
Start: 2023-12-10. Completion: 2025-04-23 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
HEC88473, Placebo, Dulaglutide (drug)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Peking University People's Hospital Beijing, Beijing Municipality, China Site recruitment: Not reported
Shijiazhuang People's Hospital Shijiazhuang, Hebei, China Site recruitment: Not reported
Start: 2022-03-15. Completion: 2024-08-01 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
dulaglutide injection (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Vanderbilt University Medical Center Nashville, Tennessee, United States Site recruitment: Not reported
Start: 2022-12-29. Completion: 2024-01-16 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Dulaglutide (drug) — also listed as: LY2189265
Where the study takes place — 7 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Medlink Hospital Opp Someshwara Jain Temple Ahmedabad, Ambavadi, India Site recruitment: Not reported
Life Care Hospital and Research Centre Bangalore, Karnataka, India Site recruitment: Not reported
Grant Medical Foundation - Ruby Hall Clinic Pune, Maharashtra, India Site recruitment: Not reported
Akshay Hospital Pune, Maharashtra, India Site recruitment: Not reported
Lifepoint Multispecialty Hsptl Wākad, Pune, India Site recruitment: Not reported
Kovai Diabetes Speciality Center and Hospital Coimbatore, Tamil Nadu, India Site recruitment: Not reported
Virinchi Hospital Hyderabad, Telangana, India Site recruitment: Not reported
Start: 2021-08-06. Completion: 2023-06-22 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Dulaglutide (drug) — also listed as: Trulicity
Placebo (drug)
Continuous glucose monitor (CGM), blinded (device) — also listed as: FreeStyle Libre Pro
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Emory University Hospital Atlanta, Georgia, United States Site recruitment: Not reported
Grady Hospital Atlanta, Georgia, United States Site recruitment: Not reported
Start: 2020-08-25. Completion: 2021-03-09 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
LY3493269 (drug)
Dulaglutide (drug) — also listed as: LY2189265
Placebo (drug)
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Anaheim Clinical Trials, LLC Anaheim, California, United States Site recruitment: Not reported
Miami Research Associates Miami, Florida, United States Site recruitment: Not reported
Clinical Trials of Texas, Inc. San Antonio, Texas, United States Site recruitment: Not reported
Glucose Intolerance; Overweight and Obesity; Drug Effect; Adiposity
Sponsor
The University of Texas Health Science Center, Houston
Countries with listed sites
United States
Registry dates and results
Start: 2020-05-15. Completion: 2023-10-06 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Cyanocobalamin (drug) — also listed as: Vitamin B12
Dulaglutide (drug) — also listed as: Trulicity
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The University of Texas Health Science Center at Houston Houston, Texas, United States Site recruitment: Not reported
Start: 2022-01-28. Completion: 2024-10-30 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Dulaglutide (drug)
Insulin Degludec (drug)
Continuous glucose monitor (device)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Prince of Wales Hospital Shatin, Hong Kong Site recruitment: Not reported
Start: 2022-10-12. Completion: 2023-05-24 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
HRS9531 (drug)
Placebo (drug)
Dulaglutide Injection (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Zhongshan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China Site recruitment: Not reported
Glucagon Like Peptide-1 (GLP-1; Delayed Gastric Emptying; Risk of Aspiration; Diabetes; Morbid Obesity
Sponsor
Children's Hospital Medical Center, Cincinnati
Countries with listed sites
United States
Registry dates and results
Start: 2024-07-08. Completion: 2026-07 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Glucagon-Like Peptide-1 receptor agonists (drug)
Point of Care Gastric Ultrasound (diagnostic_test) — also listed as: POGUS
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Cincinnati Children's Hospital Cincinnati, Ohio, United States Site recruitment: Not reported
Urine Albumin (UAlb); Glycocalyx; Arterial Stiffness
Sponsor
Attikon Hospital
Countries with listed sites
Greece
Registry dates and results
Start: 2018-02-01. Completion: 2024-12-15 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Dulaglutide (drug)
DPP-4 Inhibitors (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Attikon University General Hospital Chaïdári, Attica, Greece Site recruitment: Not reported
Start: 2023-01-06. Completion: 2024-04-09 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
dulaglutide (drug)
IBI362 (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
China-Japan Friendship Hospital Beijing, Beijin, China Site recruitment: Not reported
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
Countries with listed sites
Bangladesh
Registry dates and results
Start: 2024-09. Completion: 2025-06 (may be estimated). No results posted in this registry response.
Products and interventions (9)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Omarigliptin (drug)
Sulphonylureas (drug)
Metformin (drug)
Other DPP4-i (drug)
Thiazolidinediones (drug)
Alpha-Glucosidase Inhibitor (drug)
Glucagon-Like Peptide-1 (drug)
Receptor Agonists (GLP1RA) (drug)
SGLT2 inhibitors (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
BIRDEM General Hospital Dhaka, Bangladesh Site recruitment: Not reported
Start: 2019-03-08. Completion: 2023-05-02 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Dulaglutide Injection (drug) — also listed as: Trulicity
Saline Injection (other) — also listed as: Sodium Chloride Injection
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Grady Memorial Hospital Atlanta, Georgia, United States Site recruitment: Not reported
Emory Hospital Midtown Atlanta, Georgia, United States Site recruitment: Not reported
Emory University Hospital Atlanta, Georgia, United States Site recruitment: Not reported
Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose Metabolism Disorders; Metabolic Disease; Endocrine System Diseases; Hypoglycemic Agents; Type 2 Diabetes Mellitus (T2DM)
Sponsor
Eli Lilly and Company
Countries with listed sites
Japan
Registry dates and results
Start: 2021-04-13. Completion: 2023-04-26 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Dulaglutide (drug) — also listed as: LY2189265
Oral antihyperglycemics (drug)
Where the study takes place — 44 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Nakayama Clinic Nagoya, Aichi-ken, Japan Site recruitment: Not reported
Tosaki Clinic for Diabetes and Endocrinology Nagoya, Aichi-ken, Japan Site recruitment: Not reported
Kashiwa City Hospital Kashiwa, Chiba, Japan Site recruitment: Not reported
Kobari General Clinic Noda, Chiba, Japan Site recruitment: Not reported
Nippon Kokan Fukuyama Hospital Fukuyama-shi, Hiroshima, Japan Site recruitment: Not reported
Yamagata Naika Clinic Asahikawa, Hokkaido, Japan Site recruitment: Not reported
Hasegawa Medical Clinic Chitose, Hokkaido, Japan Site recruitment: Not reported
Yuri Ono Clinic Sapporo, Hokkaido, Japan Site recruitment: Not reported
Manda Memorial Hospital Sapporo, Hokkaido, Japan Site recruitment: Not reported
Miyanosawa Clinic of Internal Medicine and Cardiology Sapporo, Hokkaido, Japan Site recruitment: Not reported
Takabe Diabetes Clinic Himeji, Hyōgo, Japan Site recruitment: Not reported
Nakamoto Internal Medicine Clinic Mito, Ibaraki, Japan Site recruitment: Not reported
Nakakinen clinic Naka, Ibaraki, Japan Site recruitment: Not reported
Nishiyamadou Keiwa Hospital Naka, Ibaraki, Japan Site recruitment: Not reported
Hayashi Diabetes Internal Medicine Clinic Chigasaki, Kanagawa, Japan Site recruitment: Not reported
Shonan Takai Clinic Kamakura, Kanagawa, Japan Site recruitment: Not reported
Takai Internal Medicine Clinic Kamakura-shi, Kanagawa, Japan Site recruitment: Not reported
Yamagishi Clinic Sagamiono Sagamihara, Kanagawa, Japan Site recruitment: Not reported
Medical Corporation Yuga Tsuruma Kaneshiro Diabetes Clinic Yamato-shi, Kanagawa, Japan Site recruitment: Not reported
Seiryo Internal Medicine Iwanuma, Miyagi, Japan Site recruitment: Not reported
Gibo Hepatology Clinic Matsumoto, Nagano, Japan Site recruitment: Not reported
Shiraiwa Medical Clinic Kashihara, Osaka, Japan Site recruitment: Not reported
Medical Corporation Heishinkai OCROM Clinic Suita-shi, Osaka, Japan Site recruitment: Not reported
Sugiura Internal Medicine Clinic Sōka, Saitama, Japan Site recruitment: Not reported
Seiwa Clinic Adachi-ku, Tokyo, Japan Site recruitment: Not reported
Tokyo-Eki Center-building Clinic Chuo-ku, Tokyo, Japan Site recruitment: Not reported
Medical Corporation Chiseikai Tokyo Center Clinic Chuo-ku, Tokyo, Japan Site recruitment: Not reported
Fukuwa Clinic Chuo-ku, Tokyo, Japan Site recruitment: Not reported
Hachioji Diabetes Clinic Hachiōji, Tokyo, Japan Site recruitment: Not reported
Minamino Cardiovascular Hospital Hachiōji, Tokyo, Japan Site recruitment: Not reported
Yutenji Medical Clinic Meguro-ku, Tokyo, Japan Site recruitment: Not reported
Kanno Naika Mitaka, Tokyo, Japan Site recruitment: Not reported
Heishinkai Medical Group ToCROM Clinic Shinjuku-ku, Tokyo, Japan Site recruitment: Not reported
Nomura Clinic tabashi City, Tokyo, Japan Site recruitment: Not reported
Futata Tetsuhiro Clinic Fukuoka, Japan Site recruitment: Not reported
Yoshimura Clinic Kumamoto, Japan Site recruitment: Not reported
Jinnouchi Hospital Kumamoto, Japan Site recruitment: Not reported
Heiwadai Hospital Miyazaki, Japan Site recruitment: Not reported
Ota Diabetes Internal Medicine Clinic Nagano, Japan Site recruitment: Not reported
AMC Nishiumeda Clinic Osaka, Japan Site recruitment: Not reported
Kitada Clinic Osaka, Japan Site recruitment: Not reported
Osaka Metropolitan Univ Hosp Osaka, Japan Site recruitment: Not reported
Nanko Clinic Osaka, Japan Site recruitment: Not reported
Abe Clinic Ōita, Japan Site recruitment: Not reported
Start: 2022-06-07. Completion: 2024-01-12 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
LY3532226 (drug)
Placebo (drug)
Dulaglutide (drug) — also listed as: Trulicity
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Profil Institut für Stoffwechselforschung Neuss, Germany Site recruitment: Not reported
Start: 2023-09-01. Completion: 2024-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
dulaglutide injection (drug) — also listed as: diet and exercise guidance treatment
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Department of Psychiatry, First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China Site recruitment: Recruiting
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.